| Acute Leukemia |
1 |
1 |
| Stem Cell Research and Therapy |
0 |
0.99 |
| Anaphylaxis |
0 |
0.8 |
| Graft Versus Host Disease and Transplant Complications |
0 |
0.8 |
| Biologic Therapy |
0 |
0.76 |
| Remission |
0 |
0.58 |
| Transplantation |
0 |
0.98 |
| Cell Transplantation |
0 |
0.49 |
| Chemotherapy |
0 |
0.46 |
| Combination Chemotherapy |
0 |
0.41 |
| Leukemia |
0 |
0.25 |
| Residual Disease |
0 |
0.23 |
| Cytomegalovirus |
0 |
0.2 |
| Targeted Cancer Therapy |
0 |
0.2 |
| Acute Myeloblastic Leukemia |
0 |
0.16 |
| Graft Versus Host Disease |
0 |
0.16 |
| Anthracyclines |
0 |
0.12 |
| Blood |
0 |
0.12 |
| Cancer |
0 |
0.12 |
| Europe |
0 |
0.12 |
| Graft |
0 |
0.12 |
| Grant |
0 |
0.12 |
| Hematology |
0 |
0.12 |
| Hospital |
0 |
0.12 |
| Tumor |
0 |
0.12 |